Market Overview

Wells Fargo Upgrades Sientra After FDA, Financing Concerns Ease

Share:

Shares of Sientra Inc (NASDAQ: SIEN) have declined about 25 percent since the company reported its first-quarter results on May 8.

Meanwhile, the industry backdrop has improved and the near-term financing overhang on Sientra's stock has lifted with the company announcing it raised gross proceeds of $100 million in an upsized equity offering of around 17.4 million shares, according to Wells Fargo.

The Analyst

Wells Fargo’s David Maris upgraded Sientra to Outperform and raised the price target from $8 to $10.

The Thesis

Sientra’s shares came under pressure on concerns around the then-upcoming FDA panel meeting on breast implant safety and a financing overhang, Maris said in the note.

Both these concerns have been mitigated.

The FDA panel called for additional monitoring and reporting, which is a more favorable decision than an outright ban as many feared.

Maris added that, in April, the FDA approved several new styles of Sientra implants, including some textured implants, which indicate a ban may not happen. Moreover, the financing overhang has lifted with gross proceeds of $100 million being raised by the company.

Price Action

Shares of Sientra trader higher by more than 7.8 percent to $6.62 at the time of publication.

Latest Ratings for SIEN

DateFirmActionFromTo
Jun 2019UpgradesMarket PerformOutperform
Mar 2019Initiates Coverage OnMarket Perform
Aug 2018Initiates Coverage OnBuy

View More Analyst Ratings for SIEN
View the Latest Analyst Ratings

Posted-In: David Maris Wells FargoAnalyst Color Upgrades Price Target Analyst Ratings

 

Related Articles (SIEN)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
NGLInitiates Coverage On17.0
TGEInitiates Coverage On25.0
DPZMaintains300.0
SCDowngrades
JLLInitiates Coverage On
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Schneider Not Seeing Seasonal Bump In Freight Demand

Mid-Afternoon Market Update: Dow Rises 170 Points; Pivotal Software Shares Plunge